TCL Archive NCI To Boost Investigator-Initiated Grants Using 5.7% Increase, Cuts In Contracts February 9, 1996
TCL Archive Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says August 8, 1980
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive NCI To Get $1.469 billion In FY88 Appropriations Bill, An Increase Of $67 Million Over FY 1987 January 1, 1988